BRASILIA, Jan 4 (Reuters) - Brazilian health regulator
Anvisa has received data regarding the AstraZeneca
COVID-19 vaccine being produced in India from the vaccine
maker's partners in Brazil, the agency said in a statement on
Monday.
Based on the data presented by Brazilian biomedical center
Fiocruz, along with more information to be presented by the
Serum Institute of India, Anvisa said it will evaluate how
comparable the vaccine is to the shot produced in the U.K.
before it decides on possible approval for emergency use.
(Reporting by Ricardo Brito
Writing by Ana Mano
Editing by Brad Haynes and Chizu Nomiyama)